Health-related quality of life after IMRT or IMRT+ HDR brachytherapy for intermediate or high-risk prostate cancer: Five-year results of a prospective trial. This is an ASCO Meeting Abstract from the ...

Reston, VA—A new study has determined that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality. Published ...

Pharmacokinetic (PK) - pharmacodynamic (PD) study of gemcitabine (G) in a randomised phase II trial of carboplatin (C) combined with G at standard rate infusion or fixed dose rate infusion in patients ...

Recent advancements in deep learning have significantly transformed the field of nuclear medicine, specifically in the detection and analysis of bone metastases via scintigraphy. By leveraging ...

At least 1 in 5 women older than 50 in the U.S. have osteoporosis, but many don’t realize it. Women 65 years and older should have a bone density scan to screen for osteoporosis, updated guidelines ...